Experiences with a New High-Dose-Rate Brachytherapy (HDR-BT) Boost Technique for T3b Prostate Cancer
Dirk Rades(University Hospital Schleswig-Holstein), Winfried Alberti, Jochen Walz(Institut Paoli-Calmettes), Steven E. Schild(Mayo Clinic Hospital), Manuel Todorovic(Universität Hamburg), Rudolf Schwarz(Universität Hamburg), H. Thurmann(Universität Hamburg), Juergen Dunst(Martin Luther University Halle-Wittenberg), Markus Graefen(Eppendorf (Germany))
Cited by 12
Related Papers
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
|Journal of the National Comprehensive Cancer Network|2023|497